Ceredex Value Advisors LLC Sells 700 Shares of John Wiley & Sons, Inc. (NYSE:WLY)

Ceredex Value Advisors LLC reduced its position in shares of John Wiley & Sons, Inc. (NYSE:WLY) by 0.3% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 217,599 shares of the company’s stock after selling 700 shares during the quarter. Ceredex Value Advisors LLC’s holdings in John Wiley & Sons were worth $10,499,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in WLY. Mission Wealth Management LP increased its position in shares of John Wiley & Sons by 3.1% in the first quarter. Mission Wealth Management LP now owns 11,629 shares of the company’s stock valued at $443,000 after acquiring an additional 350 shares during the period. Mirae Asset Global Investments Co. Ltd. raised its position in John Wiley & Sons by 7.9% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 21,046 shares of the company’s stock valued at $778,000 after purchasing an additional 1,537 shares during the last quarter. Daiwa Securities Group Inc. lifted its holdings in John Wiley & Sons by 811.1% in the 1st quarter. Daiwa Securities Group Inc. now owns 8,200 shares of the company’s stock worth $313,000 after buying an additional 7,300 shares during the period. SG Americas Securities LLC purchased a new stake in John Wiley & Sons in the 1st quarter worth approximately $252,000. Finally, Oppenheimer & Co. Inc. purchased a new position in shares of John Wiley & Sons during the first quarter valued at approximately $226,000. Hedge funds and other institutional investors own 73.94% of the company’s stock.

Insider Activity at John Wiley & Sons

In other John Wiley & Sons news, EVP Danielle Mcmahan sold 2,318 shares of the stock in a transaction on Tuesday, October 8th. The stock was sold at an average price of $49.41, for a total value of $114,532.38. Following the completion of the transaction, the executive vice president now owns 8,978 shares in the company, valued at approximately $443,602.98. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.62% of the stock is currently owned by corporate insiders.

John Wiley & Sons Stock Performance

Shares of WLY stock opened at $49.72 on Friday. The firm has a market capitalization of $2.70 billion, a price-to-earnings ratio of -24.86 and a beta of 0.85. The stock has a fifty day moving average of $47.99 and a 200 day moving average of $43.67. John Wiley & Sons, Inc. has a 52 week low of $29.04 and a 52 week high of $51.79. The company has a quick ratio of 0.53, a current ratio of 0.57 and a debt-to-equity ratio of 1.27.

John Wiley & Sons (NYSE:WLY) last announced its earnings results on Thursday, September 5th. The company reported $0.47 earnings per share for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.08). John Wiley & Sons had a negative net margin of 6.00% and a positive return on equity of 21.59%. The company had revenue of $403.81 million for the quarter, compared to the consensus estimate of $387.40 million. During the same period in the previous year, the firm posted $0.27 EPS. The company’s revenue for the quarter was down 10.5% on a year-over-year basis.

John Wiley & Sons Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, October 24th. Stockholders of record on Tuesday, October 8th were paid a $0.352 dividend. This represents a $1.41 dividend on an annualized basis and a dividend yield of 2.83%. The ex-dividend date was Tuesday, October 8th. John Wiley & Sons’s payout ratio is presently -70.50%.

About John Wiley & Sons

John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.